Hepatitis C Treatment in Idaho County Jails
Launched by EASTERN IDAHO PUBLIC HEALTH · Jul 29, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well we can test and treat people for Hepatitis C while they are in jail in Idaho County. Hepatitis C is a virus that affects the liver, and this study aims to see if we can start treatment for those who are diagnosed while they are incarcerated. The trial will include people who are in jail for more than 10 days and not sentenced to state prison. Participants will either receive treatment in jail for 12 weeks or, if they are released before completing the full treatment, they will get medication to continue their treatment after discharge and be connected to ongoing care.
To be eligible for the study, participants must be at least 18 years old and have a confirmed diagnosis of Hepatitis C. The trial will also assess how the treatment affects their quality of life using a simple questionnaire before and after treatment. This study is important because it explores ways to improve access to care for individuals with Hepatitis C, especially those who may face challenges in receiving treatment outside of jail.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All participants greater than 18 years old and incarcerated in an Idaho county jail greater than 10 days.
- • All participants who are not sentenced to prison terms at Idaho Department of Corrections (IDOC). Participants sentenced to IDOC will receive screening and treatment per IDOC policy.
- • Participants diagnosed with HCV and qualify for the AASLD Simplified Treatment Algorithm for Treatment Nave Adults Without Cirrhosis.
- Exclusion Criteria:
- • All participants greater than 18 years old and incarcerated in an Idaho county jail greater than 10 days.
- • All participants who are not sentenced to prison terms at Idaho Department of Corrections (IDOC). Participants sentenced to IDOC will receive screening and treatment per IDOC policy.
- • Participants diagnosed with HCV and qualify for the AASLD Simplified Treatment Algorithm for Treatment Nave Adults Without Cirrhosis
About Eastern Idaho Public Health
Eastern Idaho Public Health is a dedicated public health agency committed to enhancing the well-being of communities through evidence-based practices and innovative health initiatives. As a clinical trial sponsor, it focuses on conducting rigorous research aimed at improving health outcomes, addressing public health challenges, and promoting preventive measures. With a strong emphasis on collaboration and community engagement, Eastern Idaho Public Health strives to translate research findings into actionable strategies that benefit the population it serves, ensuring that health interventions are both effective and culturally relevant.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported